机构地区:[1]重庆市肿瘤研究所妇瘤科,重庆市400030 [2]重庆医科大学放射医学教研室,重庆市400016 [3]重庆市肿瘤研究所临床检验中心,重庆市400030
出 处:《中国药房》2011年第29期2729-2731,共3页China Pharmacy
摘 要:目的:研究姜黄素固体脂质纳米粒(Cur-SLN)单用或与顺铂(DDP)联用对人卵巢癌SKOV3细胞增殖的抑制作用。方法:单用试验,分组为空白对照组、Cur组、Cur-SLN组(均以Cur计,终浓度为10、20、40、60、80μmo·lL-1);联用试验,分组为空白对照组、DDP组、DDP+Cur组及DDP+Cur-SLN组,各组DDP终浓度为1、2、3、4、5μmo·lL-1,Cur终浓度均为10μmo·lL-1,检测上述各组分别对SKOV3细胞作用24、48、72h后细胞的生长抑制率。另设立空白对照组、DDP组、Cur组、Cur-SLN组、DDP+Cur组及DDP+Cur-SLN组(DDP终浓度均为2.5μmo·lL-1,Cur终浓度均为10μmo·lL-1),检测各组对SKOV3细胞作用24h后细胞凋亡率及细胞周期调控因子Cyclin E、CDK2的表达。结果:相同浓度下,与Cur组比较,Cur-SLN组作用不同时间后细胞生长抑制率均明显升高(P<0.05);与DDP组比较,DDP+Cur组和DDP+Cur-SLN组细胞生长抑制率均明显升高(P<0.05),且DDP+Cur-SLN组明显高于DDP+Cur组(P<0.05);与空白对照组比较,5个药物组细胞阻滞主要发生在G2期,细胞凋亡率和Cyclin E、CDK2表达均明显升高(P<0.05或P<0.01),且DDP+Cur-SLN组明显高于其他组(P<0.05)。结论:Cur-SLN对人卵巢癌SKOV3细胞有明显的生长抑制及促凋亡作用,且与DDP联用有协同效果。OBJECTIVE: To investigate the effect of Curcumin-loaded solid lipid nanoparticles (Cur-SLN) alone or combined with DDP on the growth of human ovarian cancer SKOV3 cells. METHODS: Single drug test groups were divided into blank con- trol group, Cur group and Cur-SLN group (the concentration of Cur were 10, 20, 40, 60, 80 μmol. L-1). The drug combination test groups were divided into blank control group, DDP group, DDP+Cur group and DDP+Cur-SLN group (the concentration of DDP were 1, 2, 3, 4, 5 μmol.L -1, that of Cur was 10 μmol.L -1). The inhibition rate of cell growth in above groups after 24 h, 48 h and 72 h were determined. Another group was divided into blank control group, DDP group, Cur group, Cur-SLN group, DDP+Cur group and DDP+Cur-SLN group(the concentration of DDP was 2.5 μmol.L -1, that of Cur was 10 μmol.L-1). The apoptosis rate of SKOV3 cell after 24 h and the expression of cell cycle regulation factor Cyclin E, CDK2 of above groups were determined. RESULTS: With same concentration, the inhibition rate of SKOV3 cell growth in Cur-SLN group after different treatment time increased significantly, compared with Cur group (P〈0.05). Compared with DDP group, the inhibition rate of SKOV3 cell growth in DDP+Cur group and DDP+Cur-SLN group increased significantly(P〈0.05), that of DDP+Cur-SLN group was signifi- cantly higher than DDP+CUr group (P〈0.05). Compared with blank control group, the other 5 groups could more significantly cause G2 phase arrest; the apoptosis rate and the expression of Cyclin E, CDK2 were increased significantly(P〈0.05 or P〈0.01), and those of DDP+Cur-SLN group were more significantly higher than other groups(P〈0.05). CONCLUSIONS: Cur-SLN can significantly inhibit the proliferation of human ovarian cancer SKOV3 cells and induce cell apoptosis, and shows synergistic effects when combined with DDP.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...